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Two strains (B7 andZ8) of the Leuconostocmesenteroides subspeciesmesenteroides thatwere isolated fromAlgerian camelmilk from
an initial pool of 13 strains and demonstrated a high ability to inhibit the growth of Listeria spp. were selected and characterised at
the phenotypic and genotypic levels. Probiotic profiling and inhibition spectra against food borne pathogens inmixed cultures were
also investigated.Thebacteriocin produced byL.mesenteroides strain B7was identified as leucocin B by specific PCR. In vitro studies
demonstrated that both Leuconostoc mesenteroides strains exhibited amarked probiotic profile, showing high survival at low pH (2-
3 and 4) in the presence of 0.5%, 1%, and 2% of bile salts and at pH 3 in the presence of 3mg/mL pepsin. Susceptibility testing against
antimicrobial agents was also performed for both strains. When tested in a mixed culture with Listeria innocua, Listeria ivanovii, or
Staphylococcus aureus, strain B7 reduced the numbers of these species by 1.87, 1.78, and 1.38 log units, respectively. Consequently,
these two strains were found to possess good probiotic properties in vitro and a high capacity for Listeria spp. inhibition in mixed
cultures. Therefore, these strains have a favourable technological aptitude and a potential application as novel probiotic starters.
1. Introduction
Camel milk has antimicrobial activity and a good conser-
vation aptitude. Barbour et al. [1] reported that camel milk
inhibits some pathogenic bacteria because of several protec-
tive proteins found in the milk, including lysozymes, lactop-
eroxidase, lactoferrin, immunoglobulin, and vitamin C. For
these reasons, Yagil et al. [2] support that pasteurisation is not
essential for camel milk if the camels are in good health.
Camel milk composition is less stable than milk from other
animals. These variations can be caused by many factors,
such as geographical lactation, alimentary conditions, and
the breed and age of the camel [3]. Lactic acid bacteria
(LAB) from cow and goat milk have been well studied for
both antimicrobial activity and bacteriocin production [4–6].
However, few studies have been conducted on the isolation
and characterisation of LAB from camel milk [7–9] or on the
antimicrobial activity [10–12].
Several LAB species produce a wide variety of antimicro-
bials that can be used for food preservation. In a number of
instances, the inhibitory activity of LAB could be attributed to
metabolic end products such as hydrogen peroxide, diacetyl
and organic acids, and bacteriocin [13]. Currently, LAB
include (13) different bacterial genera: Lactobacillus, Leu-
conostoc, Lactococcus, Enterococcus, Streptococcus, Pediococ-
cus, Carnobacterium, Oenococcus, Weissella, Aerococcus, Tet-
ragenococcus, Vagococcus, and Bifidobacterium. These bacte-
ria are used primarily as starters in fermented food products
where they can develop certain organoleptic characteristics
and increase the time of conservation [14–17].
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LAB exhibit probiotic properties because these bacteria
are normal flora in gastrointestinal tract [18] and have no
harmful effects [19]. Moreover, the addition of antagonis-
tic bacterial preparations as protective cultures is another
approach for biopreservation [20]. In addition, possible
microbial interactions, either beneficial (cooperation) or
unfavourable (inhibition), can be achieved in mixed strain
cultures. These mixed cultures are commonly used as starter
cultures in dairy manufacturing because of the acid produc-
tion, growth rate, proteolytic activity, bacteriocin production
and sensitivity, aroma production, and phage sensitivity
of these cultures [21]. However, these technologies can be
limiting for commercial application because of the negative
impacts or the low reproducibility percentage of the response
[22]. For these reasons, the characterisation of LAB as pro-
biotic cultures should respond to several criteria, such as the
ability to survive the specific conditions of the gastrointestinal
tract, including low pH, proteolytic enzymes, and bile salt
concentrations [23].
Because these bacteria are meant to be used as protective
cultures, the inhibition pattern, safety, and functional and
technological properties of these bacteria should also be
examined.
Few studies have reported the high potential of using
Leuconostoc as a probiotic strain. Kekkonen et al. [24] showed
that the use of Leuconostoc as probiotic strain in inducing
cytokines was better than that of the probiotic Lactobacillus
strain that is presently in clinical use. In addition, Allameh
et al. [18] reported for the first time the use of Leuconostoc
mesenteroides isolated from the intestine of snakehead fish
as a potentially new probiotic for aquaculture systems for
the development of fish production. Moreover, Leuconostoc
lactis has been shown to have a potential for use as a single
starter culture in Khanoon-jeen production and could reduce
the microbial risk and fermentation processing time [25].
Additionally, Leuconostoc strains have potential as protective
cultures for vacuum packed meat products [26], and the
bacteriocins of Leuconostoc can be used as protective agents
in combination with another starter culture in fermented
meat [27]. However, the use of Leuconostoc mesenteroides
isolated from camel milk as either a probiotic strain or a pro-
tective culture has never been reported.Therefore, we isolated
and identified Leuconostoc strains from camel milk as new
probiotic or protective cultures for the first time.
2. Materials and Methods
2.1. Raw Camel Milk Sampling. Thirteen Leuconostoc strains
were isolated from four different camel milk samples, which
were collected from two different Saharan areas (Nâama and
Béchar) in SouthWestern Algeria.The first two samples were
collected from two camels (Camelus dromados) in Nâama
that differed in age (10 and 15 years old) and colour (grey
and black) but had the same lactation period (March, 2011).
The diet of the camels was based on natural Saharan plants,
such as Drinn (Arstide pungens). Samples from Béchar were
collected from brown camels aged less than 10 years in the
arid Abadla region in the period 2009–2011. Sampling was
performed under aseptic conditions bywashing the teats with
warm water containing 2% bleach and collecting the milk
in sterile bottles after hand washing with diluted alcohol.
Samples were maintained at 4∘C and were transported in
iceboxes to the laboratory for analysis.
2.2. Leuconostoc Isolation. The bioactive Leuconostoc consid-
ered in this work were isolated from the raw camel milk
as described above. All strains were stored at −80∘C and
were maintained in reconstituted skimmed milk containing
30% (w/v) glycerol. All strains were cultured in MRS broth
(Liofilchem, Teramo, Italy) at 30∘C for 24 h and were then
seeded onto MRS agar (Liofilchem) to obtain single colonies.
The wild type and reference Leuconostoc strains used in this
study belonged to the collection of our laboratory.
Based on the results obtained from the inhibitory assays,
two bioactive leuconostocs strains (B7 and Z8) were selected
and subjected to phenotypic and morphological character-
isation based on the following criteria: CO
2
production,
growth at different temperatures (4∘C, 15∘C, 30∘C, 37∘C, and
45∘C), growth at different pH (4.8 and 6.8), and growth at
different NaCl concentrations (3% and 6.5%). Additionally,
all strains were subjected to the following biochemical tests
to differentiate between Leuconostoc and lactobacilli: dextran
production on MSE medium [28], arginine hydrolysis on
M16BCP medium (Oxoid Ltd., London, UK), and citric acid
degradation on Kempler and McKay solid medium. Carbo-
hydrate fermentation was tested on MRS supplemented with
bromocresol purple as a pH indicator using the following
sugars to differentiate the subspecies of Leuconostocs: arabi-
nose,maltose, rhamnose, esculin,manitol, sorbitol, galactose,
lactose, fructose, glucose, sucrose, and xylose. All strainswere
phenotypically identified as belonging to the Leuconostoc
genus based on the following criteria: ovoid shape, Gram-
positivity, catalase negativity, vancomycin-resistance, pro-
duction of gas from glucose, lack of arginine hydrolysis, and
fermentation profiles.
2.3. Genetic Identification of Bioactive Leuconostoc Strains. A
fragment of the 16S rRNA gene of the two bioactive strains
was amplified by PCR using the universal primer pair p8FPL
(forward: 5󸀠-AGTTTGATCCTGGCTCAG-3󸀠) and p806R
(reverse: 5󸀠-GGACTACCAGGGTATCTAAT-3󸀠) [29]. The
assays comprised 100 ng of template DNA, 25 𝜇L of a mas-
ter mix (BioMix, Bioline, London, UK) (this included the
reaction buffer, dNTPs, and magnesium chloride), Taq DNA
polymerase, 25 pmol of each oligonucleotide primer, and
double-distilled water to achieve a final volume of 50 𝜇L.
Amplification conditions were as follows: denaturing at 94∘C
for 7min., 35 cycles of denaturation (94∘C for 60 sec.),
annealing (55∘C for 60 sec.), extension (72∘C for 60 sec.), and
a final extension at 72∘C for 15min. The PCR was performed
as described by Böhme et al. [30].
The two PCR products were then sequenced using the
same primers used for PCR. The sequences were analysed
with Chromas software (Griffith University, Queensland,
Australia) and aligned using Clustal-X software [31, 32].
Following alignment, these sequences were identified by
searching for sequence homology among published reference
sequences using the web BLAST tool (National Center for
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Biotechnology Information (NCBI, http://blast.ncbi.nlm.nih
.gov/) [33]. Homologies higher than 99% with respect to a
strain type were considered acceptable identifications.
2.4. Genetic Identification of Bacteriocin Produced by Leu-
conostocmesenteroides Strains. Thebacteriocins produced by
L. mesenteroides strains were identified by PCR using the
primers described by Xiraphi et al. [34]. The detection of
the following bacteriocins: mestenterocin B, mesenterocin Y,
leucoccin A, leucoccin B, and leucocin A-TAF was carried
out using the following primers: mesB, mesY, lcnA, lcnB,
and lcnA-TAF, respectively. The reaction conditions were as
described by Xiraphi et al. [34].The nucleotide sequencing of
the bacteriocin gene was performed as described above.
2.5. Probiotic Evaluation of Bioactive L. mesenteroides Strains
2.5.1. Inhibition Spectra of L. mesenteroides Strains against
Indicator Microorganisms. Preliminarily, all strains were
tested for the ability to produce antimicrobial substances
using the direct method described by Fleming et al. [35].
Inhibitory activity was investigated using the following indi-
cator bacteria: Staphylococcus aureus: 43300 (Centre Hospi-
talier Universitaire, C.H.U Oran, Algeria), Listeria innocua
(ATCC 33090), and Listeria ivanovii (ATCC 19119).
Alliquots of 80𝜇L from 18 h cultures of 107 CFUmL−1
Leuconostoc strains were spotted onto MRS agar using mul-
tipoint inoculators and were incubated at 30∘C for 24 h
[36]. Following the incubation, a semisolid Mueller Hinton
(Oxoid) medium containing 100 𝜇L of 107 CFUmL−1 of the
indicator culture was poured as an overlay. All plates were
then incubated at 37∘C for 24 h and examined for inhibition
zone formation. Inhibition was considered positive when the
width of the clear inhibition halos was ≥0.5 cm.
2.5.2. Detection of the Proteinaceous Nature of the Inhibitory
Agent. The proteinaceous nature of the inhibitory substance
was detected using an indirect method. In this method, a
Leuconostoc strain was incubated for 18 h in MRS broth at
30∘C and was then centrifuged at 8,000 rpm for 10 minutes.
Then, 100 𝜇L of the supernatant (FCS) was inoculated on
wells formed on solid MRS medium that were seeded by
indicator strains, and the wells were incubated for 24 h to 48 h
at 37∘C. Colonies surrounded by a clear zone with a diameter
greater than 2mm in the layer of the indicator culture were
considered positive. Several factors were eliminated to con-
firm the proteinous nature of the inhibitory substance, such
as lactic acid using a buffered medium and the elimination
of the effect of hydrogen peroxide by using indicator strains
with catalase enzyme such as S. aureus, Listeria innocua,
and L. ivanovii. In addition, proteolytic enzymes (trypsin-
chymotrypsin) and heat treatments of the supernatant at
different temperatures (75∘C, 80∘C, and 100∘C) were used to
identify the proteinaceous nature of the inhibitory substance.
2.5.3. pH Tolerance. Bacterial cells from overnight MRS
cultures were collected by centrifugation and were washed
with sterile phosphate buffer saline, pH 8. Centrifugation and
washing procedures were repeated three times. The bacterial
cells were resuspended in sterile PBS adjusted to pH 2, 3, or 4
andwere incubated at 37∘C for 3 h.The viable bacterial counts
were then determined in MRS agar.
2.5.4. Bile Salt Tolerance and Bile Salt Hydrolyses. Bacterial
cells from overnight MRS cultures were harvested by cen-
trifugation, washed, and resuspended in PBS (pH 8) supple-
mented with 0.5%, 1.0%, or 2.0% (w/v) oxgall (Oxoid Ltd.,
England). Viable cell counts were determined in MRS agar
after 4 h at 37∘C.
For the bile salt hydrolysis assay, overnight bacterial cul-
tures of each L. mesenteroides strain were streaked on MRS
agar, supplemented with 0.5% (w/v) oxgall, and incubated for
24 and 48 h at 37∘C. The bacterial hydrolysis of the bile salt
was visualised as altered colony morphology compared with
the control MRS plates.
2.5.5. Resistance to Pepsin. Bacterial cells from overnight
MRS cultures were collected, washed, and resuspended in
PBS buffer (pH 2 and 3) supplemented with 3mg/mL of
pepsin. The resistance of the L. mesenteroides strains was
determined by counting the initial viable cells in MRS agar
after 3 h incubation at 37∘C.
2.5.6. Haemolytic Activity. An overnight culture of the L.
mesenteroides strains was streaked in triplicates on Columbia
agar plates containing 5% (w/v) human blood and incubated
for 48 h at 30∘C. Blood agar plates were examined for signs
of 𝛽-haemolysis (clear zones around colonies), 𝛼-haemolysis
(green zones around colonies), and 𝛾-haemolysis (no zones
around colonies).
2.5.7. Antibiotic Sensitivity Test. The antibiotic susceptibility
of the two strains of L. mesenteroides (B7 and Z8) was tested
three times against 13 antibiotics using Bio-Rad discs (6mm).
L. mesenteroides strains were cultured in MRS broth at 30∘C
for 18 h and were then adjusted to a 0.5 McFarland scale and
smeared homogeneously on MRS culture plate. Antibiotic
discs were placed on the plates and incubated for 24 h at 37∘C.
The antibiotics included gentamycin (GM, 10 𝜇g), strepto-
mycin (S, 10 𝜇g), amoxicillin (AMX, 25 𝜇g), tetracycline (TE,
30 𝜇g), chloramphenicol (C, 30𝜇g), ampicillin (AM, 10 𝜇g),
erythromycin (E, 15𝜇g), cephalotin (CEF, 30 𝜇g), lincomycin
(L, 15 𝜇g), Neomycin (N, 30 𝜇g), kanamycin (K, 30 𝜇g),
penicillin (P, 6𝜇g), and vancomycin (VA, 30 𝜇g).
The inhibitory circles emerging after 24 h of incubation
were measured. Activity was assessed as sensitive (≤21mm),
intermediate (16–20mm), and resistant (≥15mm), as previ-
ously described by Liasi et al. [37].
2.6. Acidity and Growth Kinetics in Pure and Mixed Cul-
tures. To study the growth kinetics of L. mesenteroides in
pure cultures and cultures mixed with pathogens strains (L.
innocua, L. ivanovii, and S. aureus), strain B7was selected and
inoculated by streaking on solidMRSmedium and incubated
at 30∘C for 18 h. After incubation, a colony was inoculated
intoMRS liquid andwas incubated at 30∘C for 18 hours.Then,
100mL of the 18 h culture was inoculated into 10mL of
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skimmed milk containing 0.3% yeast extract and was incu-
bated at 30∘C for 18 h [38].
The bacterial populationmeasurement with the indicator
strains in pure and mixed cultures was performed by count-
ing in Nutrient Agar medium (Oxoid) to differentiate
between the colonies of Leuconostoc and Listeria spp. where
latter appear larger, the Baird Parker medium (Oxoid) to
count S. aureus and MRS to count the Leuconostoc strain.
Strain B7, which is the most efficient producer of antimi-
crobial substances, and three indicator strains, that is, L.
innocua ATCC 33090, L. ivanovii ATCC 19119 and S. aureus
ATCC 43300, were routinely subcultured in 10mL of skim
milk with 0.3% yeast extract (Oxoid) that had an initial
concentration of 107 CFU/mL for L. innocua ATCC 33090,
107 CFU/mL for L. ivanoviiATCC 19119, and 107UFC/mL for
S. aureus 43300. The three strains were inoculated separately
into 100mL of skim milk for monitoring pure cultures, and
the mixed culture was prepared by mixing a culture of the
indicator strains with the test strain B7 at a concentration of
107 CFU. The cultures were divided into tubes and incubated
at 30∘C for 24 h. Every three hours, the samples were asep-
tically withdrawn from tubes to determine the pH, titrable
acidity, and the growth rate. This experiment was repeated
three times [4].
2.7. Statistical Analysis. Several statistical models have been
proposed to estimate growth parameters from the curves
obtained by the counting methods. An ANOVA and range
tests were used to evaluate the difference between the average
of pH, acidity, and bacterial load and were represented by log
𝑁 and 𝜇max. The significance of the variation in the results
of the antimicrobial activity was evaluated by two factors:
repeatability and reproducibility [39, 40].
3. Results
3.1. Isolation, Selection, and Identification of Leuconostoc
Isolates fromRawCamelMilk. A total of thirteen Leuconostoc
strains were isolated from camel milk. The isolates exhibited
ovoid shape and were associated in short pairs and/or chains.
All isolates were Gram-positive, catalase negative, citrate
positive, able to produce CO
2
from glucose, able to produce
dextran from sucrose, and unable to hydrolyse arginine.
According to the antibacterial test, B7 and Z8 showed more
inhibition zones than the other strains. Therefore, these two
strains were selected for probiotic profiling and behavioural
studies in the presence of food borne pathogens. The results
obtained from physiological fermentation profiling (Table 1)
and 16 srRNA as a molecular technique (data not shown)
identified B7 and Z8 as L. mesenteroides and revealed 99%
homology with other sequences from the reference strains
deposited in the GenBank, according to the BLAST tool.
3.2. Genetic Identification of the Bacteriocin. Specific primers
for mesenterocin Y, mesB and Leucocin A, LcnB, and
LcnA-TAF were tested on the extracted DNA. As shown in
Figure 1, the specific primer for leucocin B produced a faint
PCR product of the expected molecular weight. Sequenc-












Figure 1:The amplification of bacteriocins produced by Leuconostoc
mesenteroides B7 strain with LcnB primers; lane M, MW marker;
lane 2, Leuconostoc mesenteroides B7B; lane 5, Leuconostoc mesen-
teroides B7󸀠B; and lane 8, Leuconostoc mesenteroides RB.
GenBank database confirmed matching with respect to a
bacteriocin (mesY, mesC, mesD, mesE, mesF, mesH, and
mesB) from L. mesenteroides (data not shown).
3.3. Antimicrobial Activity of Leuconostoc Isolates. B7 and
Z8 strains exhibited inhibitory activity against several
pathogenic bacteria, including S. aureus: 43300, L. innocua
(ATCC 33090), and L. ivanovii (ATCC 19119). The inhibition
zones were measured, and the results indicated that the
inhibition intensity and range varied depending on the Leu-
conostoc species assayed (Figure 2). Furthermore, to inves-
tigate whether the cause of the inhibition was due to the
protein substance, buffered supernatants adjusted to pH 6.8
were treated with proteolytic enzymes, which led to the
disappearance of the inhibition zones (Figure 2). This result
indicated that inhibition was caused by a proteinaceous
compound.
However, inhibition remained after heating the bacterial
supernatants to a temperature of 100∘C (data not shown),
which indicated that the causative inhibitory agent is heat
resistant. These results agree with previously reported results
[41–45].
3.4. pH Tolerance. The viable cell counts of the two L. mesen-
teroides strains after a 3 h exposure to low pH are shown
in Table 2. Strain B7 was viable at all pH levels. The results
showed a decrease of 21.17% at pH 2 but increases of 0.49%
and 5.06% at pH 3 and 4, respectively. The L. mesenteroides
strain Z8 was not viable at pH 2, but marked increases
of 7.49% and 2.43%were observed at pH 3 and 4, respectively.
The highest viability was observed at pH 4.
3.5. Bile Salt Tolerance and Bile Salt Hydrolysis. The results
of bile salt tolerance assay are shown in Table 3. The two L.
mesenteroides strains were able to grow in the presence of
0.5%, 1%, and 2% oxgall. The reduction ranges after a 4 h
exposure were 18.21%–21.27% and 1.92%–13.53% for strains
B7 and Z8, respectively. The highest resistance was observed






















Figure 2: The inhibition spectra of Leuconostoc mesenteroides strains against indicator microorganisms; B1, B2, B5, B7, and B3: Leuconostoc
mesenteroides isolated from camel milk sample 1; Z6 and Z8: Leuconostoc mesenteroides isolated from camel milk sample 2. (a1) Inhibition
of Listeria innocua (ATCC 33090) by Leuconostoc mesenteroides using a direct method. (a2) Inhibition of Listeria ivanovii (ATCC 19119) by
Leuconostocmesenteroides using a directmethod. (a3) Inhibition of Staphylococcus aureus by Leuconostocmesenteroides using a directmethod.
(b1) Antibacterial activity of Leuconostoc mesenteroides versus Listeria innocua (ATCC 33090) using a buffered medium. (b2) Antibacterial
activity of Leuconostocmesenteroides versus Listeria ivanovii (ATCC 19119) using a bufferedmedium. (b3) Antibacterial activity of Leuconostoc
versus Listeria ivanovii (ATCC 19119) using a buffered medium treated by chymotrypsin.
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Table 2: The effect of low pH on the viability of Leuconostoc mesenteroides strains.
pH2 pH3 pH4
0 h 3 h 0 h 3 h 0 h 3 h
Ln. B7 8.36 ± 0.29 6.59 8.16 8.20 8.29 ± 0.14 7.87
Ln. Z8 7.99 0 8.14 ± 0.007 8.75 ± 0.007 8.62 ± 0.007 8.83 ± 0.007
All results are expressed as log CFU/mL. Values in the same row followed by a different letter are significantly different (𝑃 < 0.05).
Ln. B7 refer to Leuconostoc mesenteroides B7.
Ln. Z8 refer to Leuconostoc mesenteroides Z8.
Table 3: The effect of oxgall concentration on the viability of Leuconostoc mesenteroides strains.
0.5% 1% 2%
0 h 4 h 0 h 4 h 0 h 4 h
Ln. B7 8.45 ± 0.007 6.86 ± 0.14 8.65 ± 0.19 6.81 ± 0.18 8.15 ± 0.007 6.66
Ln. Z8 8.35 ± 0.056 7.22 ± 0.16 8.30 ± 0.056 7.92 ± 0.056 8.33 ± 0.007 8.17 ± 0.23
All results are expressed as log CFU/mL. Values in the same row followed by a different letter are significantly different (𝑃 < 0.05).
Ln. B7 refer to Leuconostoc mesenteroides B7.
Ln. Z8 refer to Leuconostoc mesenteroides Z8.
Table 4: The effect of pepsin on the viability of Leuconostoc mesen-
teroides strains.
Pepsin (pH2) Pepsin (pH3)
0 h 3 h 0 h 3 h
Ln. B7 7.18 0 7.71 7.51
Ln. Z8 8.81 0 8.72 ± 0.071 8.25
All results are expressed as log CFU/mL. Values in the same row followed by
a different letter are significantly different (𝑃 < 0.05).
Ln. B7 refer to Leuconostoc mesenteroides B7.
Ln. Z8 refer to Leuconostoc mesenteroides Z8.
in B7. Neither L. mesenteroides strain was able to hydrolyse
bile salt.
3.6. Resistance to Pepsin. Neither strain was able to survive
at pH 2 when 3mg/mL of pepsin was added. However, a
remarkable resistance was observed at pH 3 when 3mg/mL
of pepsin was added. Strain B7 decreased by 2.6%, and strain
Z8 decreased by 5.4%. The results are shown in Table 4.
3.7. Haemolytic Activity. Neither of the Leuconostoc mesen-
teroides strainswas able to hydrolyse human blood, indicating
that these strains are nonhaemolytic bacteria.
3.8. Antibiotic Sensitivity Test. Thediameters of the inhibition
zones (inmm) of the antibiotic tested against L.mesenteroides
strains are shown in Table 5. The two strains were resistant
to kanamycin, streptomycin, tetracycline, and vancomycin
and were sensitive to amoxicillin, ampicillin, cephalotin,
chloramphenicol, erythromycin, lincomycin, and penicillin.
A moderate resistance was observed against gentamycin and
neomycin.
3.9. Kinetic Monitoring of pH Evolution and Acidity. The
evolution of pH in pure and mixed cultures can be observed
in Figures 3 and 4. A significant pH decrease was observed
in the mixed cultures after 72 h for the three indicator strains.
Thus, L. innocua, L. ivanovii, and S. aureus pure cultures were
less acidifying in milk medium as compared to the mixed
cultures. Accordingly, significant pH decreases from 6.41 ±
0.01 to 3.73 ± 0.24 for L. innocua, from 6.27 ± 0.03 to 3.87 ± 0
for L. ivanovii, and from 6.37±0.00 to 3.84±0.03 for S. aureus
were determined.
3.10. The Growth Kinetics of Pathogenic Indicator Strains Pure
Cultures and Cultures Mixed with a Leuconostoc Strain. The
maximum growth rate “𝜇max” was estimated using the
model described by Baranyi and Roberts [39]. Significant
reductions of the listerial load after the addition of the B7
protective culture were observed, as shown by a regression in
the G time. The largest bacterial regression was attributed to
Listeria innocua ATCC 33090 (Figure 5). A lower decrease in
the staphylococcal load was also observed after the addition
of strain B7.
The maximum growth rate (𝜇max) of the control L.
innocua ATCC 33090 culture was 0.243. The 𝜇max in the
presence of strain B7 was 0.148, which is a growth delay of
109.2min compared to the control (Figure 5).Listeria ivanovii
ATCC 19119 exhibited a 𝜇max of 0.219 in pure culture and
0.168 in mixed culture, which is a growth delay of 57.6min.
The 𝜇max of S. aureus ATCC 43300 was 0.338 for the control
and 0.293 in the presence of strain B7 with a growth delay of
31min.
Following the study of the growth kinetics, culture B7
showed relatively a slow growth. Bioprotective strains pro-
moted their own growth to control pathogens by inhibiting
pathogenic growth. The reductions in the listerial loads were
approximately 1.87 and 1.78 log units for L. innocua and L.
ivanovii, respectively. A reduction of approximately 1.38 log
units was observed for S. aureus, which was a smaller reduc-
tion than those observed for Listeria strains.
4. Discussion
TwoLeuconostoc strains (B7 andZ8) isolated fromcamelmilk
were characterised by their genetic profile, probiotic profile,
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Figure 3: Monitoring the pH of pure and mixed cultures of B7 strain and indicator pathogens. (a) pH variation of Leuconostoc mesenteroides
B7 and Listeria innocua strains in both pure and mixed cultures. (b) pH variation of Leuconostoc mesenteroides B7 and Staphylococcus aureus
strains in both pure andmixed cultures. (c) pH variation of Leuconostoc mesenteroides B7 and Listeria ivanovii strains in both pure andmixed
cultures. (d) pH variation comparison of Leuconostoc mesenteroides B7, Listeria innocua, Staphylococcus aureus, and Listeria ivanovii strains
in mixed culture.
and behaviour against food-borne pathogens in mixed cul-
ture. The antimicrobial activities exhibited by these strains
were sensitive to proteolytic enzymes but were heat stable;
therefore, the antimicrobial activitymay be due to heat-stable
protein or peptides.
In the present study, the genes responsible for the produc-
tion of bacteriocin were detected using LcnB primers. Inter-
estingly, L. mesenteroides B7 showed the expected molecular
weight for a leucocinB, suggesting that these strains should be
examined on the genetic and functional levels.Themolecular
characterisation by the 16s rRNA gene was in agreement with
the phenotypic characterisation. The strains exhibited high
similarity among themselves and with sequences from the
reference strains in GenBank.
Probiotic foods should maintain the viability of the
probiotic bacteria during the preparation and shelf life of the
products and during the transit through the gastrointestinal
tract to exert their beneficial effects [44]. Selecting potential
probiotic strains that can effectively perform in the gastroin-
testinal (GI) tract is a significant challenge [45]. Therefore,
we characterised the probiotic profiles of two strains of L.
mesenteroides (B7 and Z8). Acid and bile tolerance were
two fundamental properties that indicate the ability of these
microorganisms to survive through the host GI tract [46].
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Figure 4:The acidity kinetics of LeuconostocmesenteroidesB7 strain and indicator pathogens in pure andmixed cultures. (a) Acidity variation
expressed in dornic degree for Leuconostoc mesenteroides B7 and Listeria ivanovii in both pure and mixed cultures. (b) Acidity variation
expressed in dornic degree for Leuconostoc mesenteroides B7 and Staphylococcus aureus in both pure andmixed cultures. (c) Acidity variation
expressed in dornic degree for Leuconostoc mesenteroides B7 and Listeria innocua in both pure and mixed cultures. (d) Comparison of
acidity variation expressed in dornic degree for Leuconostoc mesenteroides B7 Listeria ivanovii, Staphylococcus aureus, and Listeria innocua,
respectively, in mixed culture.
Argyri et al. [47] found no resistance to low pH for 16 L.
mesenteroides strains from a total of 17. One strain was able to
resist exposure to pH 2.5, but the viable counts ofmost strains
were less than 1 logCFU/mL after 3 h. Our results showed a
good viability for the two L. mesenteroides when exposed to
the acidic condition of the stomach (pH 3 and 4). The viable
count of strain B7 in pH 2 was 6.59 log CFU/mL, but strain
Z8 showed no viability.
The presence of bile salt in the small intestine is another
challenge for probiotic bacteria. The two L. mesenteroides
strains survived well in the presence of different concentra-
tions of bile salt (0.5, 1, and 2% (w/v)), with some loss in via-
bility. A recent study showed that bile salt affected the growth
rate and ability of isolated L. mesenteroides subsp. mesen-
teroides [18]. Surono [48] found that L. mesenteroides subsp.
mesenteroides IS-27526 had a poor survival rate of 4.37
logCFU/mL in the presence of 0.3% oxgall (w/v). Allameh
et al. [18] showed the tolerance of L. mesenteroides subsp.
mesenteroides after 2, 4, and 8 h incubation periods in pres-
ence of 0.0, 0.15, and 0.3% of bile salt, respectively.The results
of this study showed not only viability but also proliferation
in all three concentrations for all incubation periods.
A probiotic needs to survive conditions such as low pH,
pepsin, and pancreatin activity and bile while adhering to
epithelial cells and competitively excluding pathogens [49].
In our study, L. mesenteroides strain B7 was viable at pH 2,
but neither strain showed viability at pH 2 when 3mg/mL of
pepsin was added. However, both strains were viable at pH 3
and 4 with pepsin supplementation. A similar study by Seo
et al. [50] showed that L. mesenteroides YML003 exhibited a
higher survival of 1⋅7⋅105 CFU/mL after exposure to artificial
gastric juices, with an initial cell number of 2⋅5⋅108 CFU/mL.
The absence of haemolytic activity and antibiotic resis-
tance are considered safety prerequisites for the selection of
10 BioMed Research International
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Figure 5: The growth kinetics of Leuconostoc mesenteroides B7 strain and indicator pathogens in pure and mixed cultures. (a) Graphical
representation of the growth kinetics expressed in log𝑁 of Leuconostoc mesenteroides B7 and Listeria ivanovii in pure andmixed cultures. (b)
Graphical representation of the growth kinetics expressed in log 𝑁 of Leuconostoc mesenteroides B7 and Staphylococcus aureus in pure and
mixed cultures. (c) Graphical representation of the growth kinetics expressed in log𝑁 of Leuconostoc mesenteroides B7 and Listeria innocua
in pure and mixed cultures. (d) Graphical representation of the growth kinetics expressed in log𝑁 of Leuconostoc mesenteroides B7, Listeria
ivanovii, Staphylococcus aureus, and Listeria innocua, respectively, in mixed culture.
a probiotic strain [51]. No zones were detected around the
colonies of the two L. mesenteroides strains when grown in
Columbia human blood agar, suggesting that there was no 𝛾-
haemolytic activity in vitro. The lack of 𝛾-haemolytic activity
is a desirable trait in probiotic bacteria. Several authors have
shown similar results [18–47].
In addition, the two strains were resistant to kanamycin,
streptomycin, tetracycline, and vancomycin but were sensi-
tive to amoxicillin, ampicillin, cephalotin, chloramphenicol,
erythromycin, lincomycin, and penicillin. Moderate resis-
tance was observed against gentamycin and neomycin. Our
results agree with those obtained in previous studies; the
observed sensitivity to ampicillin, cephalotin, erythromycin,
lincomycin, and penicillin and resistance to vancomycin are
similar to results obtained by Zarour et al. [52], and sensitivity
to chloramphenicol and ampicillin was also observed by
Allameh et al. [18]. All studies showed resistance to van-
comycin in L. mesenteroides strains. Vancomycin resistance
is a general intrinsic feature that is linked to the presence of
a pentadepsipeptide with a C terminal-lactate instead of a d-
alanine in the peptidoglycan [53]. Few reports are available
on other antibiotics.
BioMed Research International 11
Table 5: Antibiotic susceptibility of Leuconostoc mesenteroides strains.
Antibiotics Symbol 𝜇g/disc Clear zone diameter (mm)
Z B7 Z8
Amoxicillin AMX 25 25 S 25 S
Ampicillin AM 10 23 S 24 S
Céphalotin CEF 30 23 S 24 S
Chloramphenicol C 30 28 S 27 S
Erythromycin E 15 27 S 28 S
Gentamycin GM 10 18 I 18 I
Kanamycin K 30 12 R 13 R
Lincomycin L 15 25 S 25 S
Neomycin N 30 16 I 16 I
Penicillin P 6 23 S 24 S
Streptomycin S 10 14 R 15 R
Tetracycline TE 30 14 R 14 R
Vancomycin VA 30 00 R 00 R
R: resistance, I: intermediate, and S: sensitive.
Table 6: Statistical analysis of the growth kinetics (variance analysis).
Variance analysis
L. ivanovii L. innocua St. aureus L. ivanovii L. innocua St. aureus
Test number 𝑃 2 2 2 Repeatability variance 𝜎2
𝑟
0.091 0.144 0.161
Result number𝑁 20 20 20 cv repeatability 1.20% 2.17% 1.17%
Standard deviation 0.098 0.049 0.091 Reproducibility variance 𝜎2
𝑅
0.22 0.441 2.673
Variance 0.009 0.002 0.008 cv reproducibility 3.42% 7.54% 13.52%
Mean (Log𝑁)
8.00 8.065 8.22
SD, Var, and mean at 9 h of incubation.
Our in vitro studies demonstrated that the two L. mesen-
teroides strains had good probiotic profiles. These strains
exhibited high viability at low pH levels, both in the presence
of 2% of bile salt and in the presence of pepsin. These strains
have acceptable susceptibility antibiotic profiles and are
nonhaemolytic bacteria. L. mesenteroides strains B7 and Z8
could be ideal probiotic candidates.
These interactions can be the stimulation of one or more
microorganism or may correspond to the inhibition of
growth or metabolic activity. Inhibition may occur through
the production of inhibitory substances or when one of the
twomicroorganisms is inhibited by another. Inhibition could
also be induced by reciprocal competition [54, 55].Therefore,
to study the behaviour of these two strains against food-borne
pathogens, a kinetic profile of these strains was measured in
both pure and mixed cultures.
Monitoring the pH and acidity showed a significant vari-
ability between pure and mixed culture, a result that can be
explained by the production of organic acids (lactic and acetic
acids). Therefore, we can conclude that the incubation time
positively influenced the performance of the L. mesenteroides
strains. Consequently, we can see that the amount of acid
produced varies depending on the life stage of the bacterium.
The growth curve analysis in the mixed cultures showed
a significant reduction of pathogen bacteria growth after 9 h
of incubation during the late exponential phase of growth,
which can explain the inhibition of the B7 strain towards Lis-
teria and Staphylococcus through the production of inhibitory
substances such as bacteriocins. Similar results were reported
by Lacroix and Millette [56]. The antimicrobial activity of
bacteriocin-producing LAB against pathogens was explained
by the production of bacteriocins in broth cultures, whichwas
estimated to be maximal after 9 hours of incubation, where
the maximum number of bacteria had been attained in the
early stationary phase of growth.
Study of the antimicrobial activity against L. ivanovii
ATCC 19119 showed a small variation of repeatability (giving
a lower limit of the variability of results), which indicates an
internal dispersion close to the results in homogeneous coef-
ficients of repeatability (1.54%, 1.71%, and 1.76%) (Table 6).
Conversely, the pathogen strains showed variability in their
growth rates, meaning that the observed potential showed
an inhomogeneous distribution indicated by a coefficient of
reproducibility of 3.48% (Table 6). The estimation of this
activity against S. aureus ATCC 43300 displayed a minor,
insignificant variability in the coefficients of repeatability
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(1.60%, 2.65%, and 0.82%) (Table 6), which is explained by a
lower antistaphylococcal capacity than the antilisterial capac-
ity of L. mesenteroides B7.
5. Conclusion
In conclusion, the results of this study showed that the two
strains of Leuconostoc mesenteroides (B7 and Z8) were found
to possess good probiotic properties in vitro. Moreover,
the kinetic studies showed that these two strains, especially
B7, can be used as protective cultures to inhibit pathogenic
bacteria growth in food. Therefore, these strains are good
candidates for further investigation with in vivo studies to
elucidate their potential health benefits and in fermentation
studies to assess their technological characteristics for appli-
cations as novel probiotic starters.
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